SCHEDULE 13G

Company

NEUROCRINE BIOSCIENCES INC

Filed

April 19, 2001

Accession Number

0000950127-01-000264

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →